Menu
  • About Currax
    • Our Purpose and Values
    • Leadership
    • Corporate & Business Development
    • Company Culture
  • Products
    • Branded Products
      • CONTRAVE®
      • ONZETRA® Xsail®
      • SILENOR®
      • TREXIMET®
    • Generic Products
    • Innovation
      • About Clinical Trials
      • Currax Pharmaceuticals Clinical Trials
      • Independent Research and Educational Grants
  • Responsibility
    • Currax Compliance Program and Annual Declaration
    • Currax Code of Business Conduct and Ethics
    • Currax Data Subject Request
    • State Disclosures
  • MEDIA
    • Press Releases
    • Video Library
    • Currax in the News
  • Careers
    • Benefits
    • EEO Statement
    • Search Jobs
    • Disclaimer/Warning
  • Contact Us
Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
2019
September 27, 2019

Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.

Read more
September 26, 2019

Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®

Read more
May 1, 2019

Currax™ Holdings USA LLC Announces Launch and Close of Acquisition

Read more

Currax Pharmaceuticals LLC. All rights reserved. This information is intended only for residents of the United States.

  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Sitemap
  • Report An Adverse Event